UK approves Novo Nordisk's Wegovy pill, expanding obesity treatment access to patients who avoid injections.
Novo Nordisk A/S's Wegovy pill was approved in the UK, opening up the obesity market to people who are wary of taking a shot.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near United Kingdom
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
Briefings
More story pages
Federal inspectors clear ByHeart infant formula plant of causing botulism outbreak, cite contaminated ingredients as likely cause in new report
Federal inspectors found no evidence that ByHeart's infant formula production process caused a botulism outbreak that sickened dozens of babies, according to a new report that pointed to contaminated ingredients as a more likely culprit.
Two children die from measles as England reports 100 new infections
Two children have died from measles in England, where 100 new infections have been reported.
CDC takes emergency measures against New World screwworm after parasitic infection found in US cattle for first time in decades
The US Centers for Disease Control and Prevention has started taking emergency measures against New World screwworm after the dangerous parasitic infection was detected in cattle in the country for the first time in decades.
Novo Nordisk launches Wegovy 8 pills, first daily GLP-1 weight loss option
Novo Nordisk's Wegovy 8 pills (semaglutide tablets) are now the first daily GLP-1 weight loss option.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.